Cargando…

Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies

The use of human post-mortem brain material is of great value when investigating which pathological mechanisms occur in human brain, and to avoid translational problems which have for example been evident when translating animal research into Alzheimer disease (AD) clinical trials. The amyloid β (Aβ...

Descripción completa

Detalles Bibliográficos
Autores principales: Haytural, Hazal, Lundgren, Jolanta L., Köse, Tansu B., Jordà-Siquier, Tomàs, Kalcheva, Marinela, Seed Ahmed, Mohammed, Winblad, Bengt, Sundström, Erik, Barthet, Gaël, Tjernberg, Lars O., Frykman, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794468/
https://www.ncbi.nlm.nih.gov/pubmed/31649526
http://dx.doi.org/10.3389/fnagi.2019.00273
_version_ 1783459300958535680
author Haytural, Hazal
Lundgren, Jolanta L.
Köse, Tansu B.
Jordà-Siquier, Tomàs
Kalcheva, Marinela
Seed Ahmed, Mohammed
Winblad, Bengt
Sundström, Erik
Barthet, Gaël
Tjernberg, Lars O.
Frykman, Susanne
author_facet Haytural, Hazal
Lundgren, Jolanta L.
Köse, Tansu B.
Jordà-Siquier, Tomàs
Kalcheva, Marinela
Seed Ahmed, Mohammed
Winblad, Bengt
Sundström, Erik
Barthet, Gaël
Tjernberg, Lars O.
Frykman, Susanne
author_sort Haytural, Hazal
collection PubMed
description The use of human post-mortem brain material is of great value when investigating which pathological mechanisms occur in human brain, and to avoid translational problems which have for example been evident when translating animal research into Alzheimer disease (AD) clinical trials. The amyloid β (Aβ)-peptide, its amyloid precursor protein (APP) and the intermediate APP-c-terminal fragments (APP-CTFs) are all important players in AD pathogenesis. In order to elucidate which APP CTF that are the most common in brain tissue of different species and developmental stages, and whether there are any differences in these fragments between AD and control brain, we investigated the occurrence of these fragments using different APP c-terminal antibodies. We noticed that whereas the conventional APP-CTFα and CTFβ fragments were most prominent in rat and mouse brain tissue, the major western blotting band detected in human, macaque and guinea pig was of approximately 20 kDa in size, possibly corresponding to the newly discovered APP-CTFη. However, this band was also intensely stained with a total protein stain, as well as by several other antibodies. The staining intensity of the 20 kDa band by the APP antibodies varied considerably between samples and correlated with the staining intensity of this band by the total protein stain. This could potentially be due to non-specific binding of the antibodies to another protein of this size. In-gel digestion and mass spectrometry confirmed that small amounts of APP were present in this band, but many other proteins were identified as well. The major hit of the mass spectrometry analysis was myelin basic protein (MBP) and a myelin removal protocol removed proportionally more of the 20 kDa APP band than the full-length APP and APP-CTFα/β bands. However, the signal could not be immunodepleted with an MBP antibody. In summary, we report on a potentially non-specific western blotting band of approximately 20 kDa and call for precaution when analyzing proteins of this size in human brain tissue.
format Online
Article
Text
id pubmed-6794468
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67944682019-10-24 Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies Haytural, Hazal Lundgren, Jolanta L. Köse, Tansu B. Jordà-Siquier, Tomàs Kalcheva, Marinela Seed Ahmed, Mohammed Winblad, Bengt Sundström, Erik Barthet, Gaël Tjernberg, Lars O. Frykman, Susanne Front Aging Neurosci Neuroscience The use of human post-mortem brain material is of great value when investigating which pathological mechanisms occur in human brain, and to avoid translational problems which have for example been evident when translating animal research into Alzheimer disease (AD) clinical trials. The amyloid β (Aβ)-peptide, its amyloid precursor protein (APP) and the intermediate APP-c-terminal fragments (APP-CTFs) are all important players in AD pathogenesis. In order to elucidate which APP CTF that are the most common in brain tissue of different species and developmental stages, and whether there are any differences in these fragments between AD and control brain, we investigated the occurrence of these fragments using different APP c-terminal antibodies. We noticed that whereas the conventional APP-CTFα and CTFβ fragments were most prominent in rat and mouse brain tissue, the major western blotting band detected in human, macaque and guinea pig was of approximately 20 kDa in size, possibly corresponding to the newly discovered APP-CTFη. However, this band was also intensely stained with a total protein stain, as well as by several other antibodies. The staining intensity of the 20 kDa band by the APP antibodies varied considerably between samples and correlated with the staining intensity of this band by the total protein stain. This could potentially be due to non-specific binding of the antibodies to another protein of this size. In-gel digestion and mass spectrometry confirmed that small amounts of APP were present in this band, but many other proteins were identified as well. The major hit of the mass spectrometry analysis was myelin basic protein (MBP) and a myelin removal protocol removed proportionally more of the 20 kDa APP band than the full-length APP and APP-CTFα/β bands. However, the signal could not be immunodepleted with an MBP antibody. In summary, we report on a potentially non-specific western blotting band of approximately 20 kDa and call for precaution when analyzing proteins of this size in human brain tissue. Frontiers Media S.A. 2019-10-09 /pmc/articles/PMC6794468/ /pubmed/31649526 http://dx.doi.org/10.3389/fnagi.2019.00273 Text en Copyright © 2019 Haytural, Lundgren, Köse, Jordà-Siquier, Kalcheva, Seed Ahmed, Winblad, Sundström, Barthet, Tjernberg and Frykman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Haytural, Hazal
Lundgren, Jolanta L.
Köse, Tansu B.
Jordà-Siquier, Tomàs
Kalcheva, Marinela
Seed Ahmed, Mohammed
Winblad, Bengt
Sundström, Erik
Barthet, Gaël
Tjernberg, Lars O.
Frykman, Susanne
Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
title Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
title_full Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
title_fullStr Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
title_full_unstemmed Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
title_short Non-specific Detection of a Major Western Blotting Band in Human Brain Homogenates by a Multitude of Amyloid Precursor Protein Antibodies
title_sort non-specific detection of a major western blotting band in human brain homogenates by a multitude of amyloid precursor protein antibodies
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794468/
https://www.ncbi.nlm.nih.gov/pubmed/31649526
http://dx.doi.org/10.3389/fnagi.2019.00273
work_keys_str_mv AT hayturalhazal nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT lundgrenjolantal nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT kosetansub nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT jordasiquiertomas nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT kalchevamarinela nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT seedahmedmohammed nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT winbladbengt nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT sundstromerik nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT barthetgael nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT tjernberglarso nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies
AT frykmansusanne nonspecificdetectionofamajorwesternblottingbandinhumanbrainhomogenatesbyamultitudeofamyloidprecursorproteinantibodies